Abstract
Sulphonamide idiosyncratic toxicosis has been reported in 28 dogs. Non-septic polyarthritis and fever occurring after 8 to 21 days therapy was the most common manifestation. Of 22 dogs with this syndrome, 7 were Doberman Pinschers. In humans, inherited decreased ability to detoxify sulphonamide hydroxylamine metabolites (as reflected in an in vitro mononuclear leukocyte (MNL) toxicity assay) has been associated with susceptibility to sulphonamide idiosyncratic toxicity. We have demonstrated that microsomes obtained from the liver of a dog were capable of metabolizing sulphamethoxazole to sulphamethoxazole hydroxylamine (SMX-HA). Production of SMX-HA was an NADPH dependent process and the yield was increased by the presence of 1 mmol/L ascorbic acid. SMX-HA was toxic to isolated MNL from mixed breed dogs (MBD) and Doberman Pinschers. The toxicity of SMX-HA to MNL from Dobermans was significantly different from that to MNL from MDB. MNL from 7 out of 15 Dobermans (including a dog with a history of an idiosyncratic reaction to a sulphonamide) had an LD-50 (concentration of SMX-HA required to produce 50% cytotoxicity in MNL) < 100 μmol/L, while MNL from 0 out of 10 MBD had an LD-50 < 100 μmol/L. These results suggest that the basis for the observed predisposition of Dobermans to sulphonamide idiosyncratic toxicity may be a limited capacity to detoxify the hydroxylamine metabolites of sulphonamides.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anderson, J.A. and Adkinson, N.F., 1987. Allergic reactions to drugs and biologic agents. Journal of American Medical Association, 258, 2891–2899
Anderson, W.I., Campbell, K.L., Wilson, R.C. and Goetsch, D.D., 1984. Hepatitis in a dog given sulfadiazine-trimethoprim and cyclophosphamide. Modern Veterinary Practice, 20, 115
Cribb, A.E., Leeder, J.S., Dosch, H.M. and Spielberg, S.P., 1989. Glutathione mediated inhibition of sulfamethoxazole hydroxylamine cytotoxicity. Proceedings of the International Union of Toxicology Congress, Brighton, UK, 1989, abs. 401
Davies, L.E., 1984. Hypersensitivity reactions induced by antimicrobial drugs. Journal of the American Veterinary Medical Association, 185, 1131–1136
Eyanagi, R., Shigematsu, H., Yoshida, K. and Yoshimura, H., 1982. Enhancement of sulfanilamide N4-hydroxylase activity in kidney and liver microsomes of rats by pretreatment with 3-methylcholanthrene type-polychlorinated biphenyl. Journal of Pharmacobiology and Dynamics, 5, 853–858
Giger, U., Werner, L.L., Millichamp, N.J. and Gorman, N.T., 1985. Sulfadiazine-induced allergy in six Doberman Pinschers. Journal of the American Veterinary Medical Association, 186, 479–484
Grondalen, J., 1987. Trimethoprim-sulfonamide induced polyarthritis. Veterinary Record, 121, 155
Harvey, R.G., 1987. Possible sulfadiazine-trimethoprim induced polyarthritis. Veterinary Record, 120, 537–8
Lees, G.E., Rogers, K.S. and Troy, G.C., 1986. Polyarthritis associated with sulfadiazine administration in a Labrador Retriever dog. Southwest Veterinarian, 37, 13–17
Mandell, G.L. and Sande, M.A., 1985. Sulfornamides, trimethoprin-sulfamethoxazole, and agents for urinary tract infections. In: A.G. Gilman, L.S. Goodman, T.W. Rall and F. Murad (eds.), The Pharmacological Basis of Therapeutics, (Macmillan, New York), 1095–1114
Nesbitt, G.H., 1986. Cutaneous drug eruptions in small animals. Clinics in Dermatology, 4, 190–193
Park, B.K., Coleman, J.W. and Kitteringham, N.R., 1987. Drug disposition and drug hypersensitivity. Biochemical Pharmacology, 36, 581–590
Paul, A.J., Tranquilli, W.J., Seward, R.L., Todd, K.S. and DiPietro, J.A., 1987. Clinical observations in Collies given ivermectin orally. American Journal of Veterinary Research, 48, 684–685
Rieder, M.J., Uetrecht, J., Shear, N.H. and Spielberg, S.P., 1988. Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfornamides. Journal of Pharmacology and Experimental Therapeutics, 244, 724–728
Rieder, M.J., Uetrecht, J., Shear, N.H., Cannon, M., Miller, M. and Spielberg, S.P., 1989. Diagnosis of sulfonamide hypersensitivity reactions by in-vitro ‘rechallenge’ with hydroxylamine metabolites. Annals of Internal Medicine, 110, 286–289
Scott, D.W., Barrett, R.E. and Tangorra, L., 1976. Drug eruption associated with sulfornamide treatment of vertebral osteomyelitis in a dog. Journal of the American Veterinary Medical Association, 168, 1111–1114
Scott, D.W., Smith, F.W.K. and Smith, C.A., 1986. Erythema multiforme and pemphigus-like antibodies associated with sulfamethoxazole-trimethoprim administration in a dog with polycystic kidneys. Canine Practice, 13, 35–38
Shear, N.H., Spielberg, S.P., Grant, D.M., Tang, B.K. and Kalow, W., 1986. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Annals of Internal Medicine, 105, 179–184
Shear, N.H. and Spielberg, S.P., 1988. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. Journal of Clinical Investigation, 82, 1826–32
Spielberg, S.P., 1980. Acetaminophen toxicity in human leukocytes in vitro. Journal of Pharmacology and Experimental Therapeutics, 213, 395–398
Spielberg, S.P., 1983. In vitro human pharmacogenetics of reactive drug metabolite detoxification. In: S.M. Macleod, A.B. Okey and S.P. Spielberg (eds.), Developmental Pharmacology, (Alan R. Liss, New York), 107–118
Taksda, T., 1987. [Polyarthritis and fever associated with trimethoprim-sulfadiazine administration in two dogs.] Norsk Veterinaertidsskrift, 99, 725–727 (Norwegian with English abstract)
Thornburg, L.P., 1988. A study of canine hepatobiliary disease, Part 5: Drug-induced hepatopathies. Companion Animal Practice, 2, 17–21
Toth, D.M. and Derwelis, S.K., 1980. Drug-induced hepatitis in a dog. Veterinary Medicine/Small Animal Clinician, 75, 421–422
Utrecht, J., Zahid, N., Shear, N.H. and Biggar, W.D., 1988. Metabolism of dapsone to a hydroxylamine by human neutrophils and mononuclear cells. Journal of Pharmacology and Experimental Therapeutics, 245, 274–279
Van Cauteran, H., Marsboom, R., Vandenberghe, J. and Will, J.A., 1983. Safety studies evaluating the effect of mebendazole on liver function in dogs. Journal of the American Veterinary Medical Association, 183, 93–98
Vree, T.B. and Hekster, Y.A., 1985. Pharmacokinetics of sulfonamides revisited. Antibiotics and Chemotherapeutics, 34, 1–208
Vree, T.B., Reekers-Ketting, J.J., Hekster, C.A. and Nouws, J.F.M., 1983. Acetylation and deacetylation of sulfonamides in dogs. Journal of Veterinary Pharmacology and Therapeutics, 6, 153–156
Weber, W.W. and Hein, D.W., 1985. N-Acetylation pharmacogenetics. Pharmacological Reviews, 37, 25–79
Werner, L.L. and Bright, J.M., 1982. Drug-induced immune hypersensitivity disorders in two dogs treated with trimethoprim-sulfadiazine: case reports and drug challenge studies. Journal of the American Animal Hospital Association, 19, 783–790
Wuhr, P., 1987. Possible trimethoprim-sulphonamide induced polyarthritis. Veterinary Record, 120, 291
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cribb, A.E., Spielberg, S.P. An in vitro investigation of predisposition to sulphonamide idiosyncratic toxicity in dogs. Veterinary Research Communications 14, 241–252 (1990). https://doi.org/10.1007/BF00347744
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00347744